(Q39819133)

14 September 2017

title

HIV type-1 entry inhibitors with a new mode of action (English)

1 reference

14 September 2017

0 references

Ryan C Fink

1

1 reference

14 September 2017

Bill Roschek

series ordinal

2

1 reference

14 September 2017

Randall S Alberte

series ordinal

3

1 reference

14 September 2017

publication date

1 January 2009

1 reference

Antiviral Chemistry & Chemotherapy

14 September 2017

published in

1 reference

14 September 2017

volume

19

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

243-255

1 reference

HIV and AIDS: 20 years of science

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Natural products as sources of new drugs over the last 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

The evolving role of natural products in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Characterization of antiviral activity of a sesquiterpene, triptofordin C-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Inhibition of HIV infection by flavanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Biological evaluation of proanthocyanidin dimers and related polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Versatile new ion source for the analysis of materials in open air under ambient conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Antiviral effect of catechins in green tea on influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

HIV co-receptor inhibitors as novel class of anti-HIV drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Medicinal benefits of green tea: Part I. Review of noncancer health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

The role of CD4 and its downmodulation in establishment and maintenance of HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020901900604

10.1177/095632020901900604

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference